Effects of fluoride on insulin signaling and bone metabolism in ovariectomized rats

• Autor(a) principal: Pereira, Amanda Gomes [UNESP]
• Data de Publicação: 2017
• Outros Autores: Chiba, Fernando Yamamoto [UNESP], Lima Coutinho Mattera, Maria Sara de [UNESP], Pereira, Renato Felipe [UNESP], Alves Nunes, Rita de Cassia [UNESP], Saori Tsosura, Thais Veronica [UNESP], Okamoto, Roberta [UNESP], Sumida, Doris Hissako [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1016/j.jtemb.2016.09.007; http://hdl.handle.net/11449/162273
• topic: Fluoride; Insulin resistance; Osteoporosis; Bone loss

Fluoride is an essential trace element for the maintenance of bone health owing to its capacity to stimulate proliferation and osteoblastic activity that can lead to increased bone formation. However, excessive sodium fluoride (NaF) intake can impair carbohydrate metabolism thereby promoting hyperglycemia, insulin resistance, and changes in insulin signaling. Thus, this study aimed to evaluate the effect of chronic treatment with NaF in bone metabolism, insulin signaling, and plasma concentrations of glucose, insulin, tumor necrosis factor-alpha (TNF-alpha), osteocalcin (OCN), and fluoride in ovariectomized rats. Thirty-two ovariectomized Wistar rats were randomly distributed into two groups: Control (OVX-C) and those undergoing treatment with NaF (50 mg F/L) in drinking water for 42 days (OVX-F). Glucose and insulin levels were assessed, followed by homeostasis model assessment of insulin resistance (HOMA-IR). Akt serine phosphorylation was evaluated by western blotting. Plasma concentrations of TNF-alpha and OCN were evaluated by ELISA. The left and right tibia was collected for immunohistochemical and histomorphometric analysis, respectively. Chronic treatment with NaF promoted insulin resistance, decreased insulin signal, increased plasma concentration of insulin, fluoride, OCN and TNF-alpha, decreased trabecular bone area of the tibia, and caused changes in bone metabolism markers in ovariectomized rats. These results suggest the need for caution in the use of NaF for the treatment of osteoporosis, especially in postmenopausal woman. (C) 2016 Published by Elsevier GmbH.